EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bacterial Aminopeptidase-Activated Peptide Prodrug Enables Species-Selective Targeting of Pseudomonas aeruginosa

Qingtian Gong iD, Silvia Synowsky, Aisling Lynch, John R F B Connolly iD, Neeladri Sekhar Roy, Sally L Shirran, Megan Bergkessel iD, Marc Devocelle iD, Clarissa M Czekster iD

ACS Infectious Diseases · 11.09.2026 · 12 (9) · 3092-3103

DOI: 10.1021/acsinfecdis.6c00281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 20.08.2026. Verfasst von Qingtian Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biomolecular Sciences building, School of Biology, University of St Andrews, North HaughKY16 9ST, U.K. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Prodrugs, Aminopeptidases, Anti-Bacterial Agents. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Surgeons in Ireland, Tenovus, University College Dublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa is an adaptable organism, frequently found in chronic infections, and for which antimicrobial resistance is a growing concern. Therefore, there is an urgent need for alternative therapeutic strategies. Cationic antimicrobial peptides (AMPs) offer potent bactericidal activity but suffer from limited selectivity and potential host toxicity. To enhance species-specific targeting, we designed two prodrug variants of the AMP D-Bac8CLeu2,5─EEEE-D-Bac8CLeu2,5 and ELEG-D-Bac8CLeu2,5─engineered for activation by the P. aeruginosa extracellular aminopeptidase PaAP. While both prodrug motifs effectively neutralized the positive charge of D-Bac8CLeu2,5 and prevented DNA–peptide complex formation, EEEE-D-Bac8CLeu2,5 showed negligible antimicrobial activity due to slow and incomplete activation. In contrast, ELEG-D-Bac8CLeu2,5 underwent rapid PaAP-mediated activation, restoring bactericidal activity in planktonic cultures and biofilms. PaAP contributed significantly to complete prodrug activation, particularly within biofilms, where the accumulation of partially activated intermediates correlated with biphasic killing kinetics. The prodrug showed reduced activity against other ESKAPEE pathogens, demonstrating selective activation by P. aeruginosa. Experiments selecting resistant bacteria revealed distinct mutations in lipopolysaccharide biosynthesis pathways for D-Bac8CLeu2,5 and the prodrug, with limited cross-resistance. These findings establish aminopeptidase-activated AMP prodrugs as a promising approach for species-selective antimicrobial therapy and highlight the feasibility of exploiting bacterial enzymes for controlled antimicrobial peptide activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaProdrugsAminopeptidasesAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial ProteinsAntimicrobial PeptidesBiofilmsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Pseudomonas aeruginosaaminopeptidaseantibiofilmantimicrobial peptidebiofilmcationicprodrug

Substanzen

ProdrugsAminopeptidasesAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial ProteinsAntimicrobial Peptides

Autor:innen und Institutionen

  • Biomolecular Sciences building, School of Biology, University of St Andrews, North HaughKY16 9ST, U.K.
  • BSRC Mass Spectrometry and Proteomics Facility, Schools of Biology and Chemistry, University of St Andrews, North Haugh, St AndrewsKY16 9ST, U.K.
  • Department of Chemistry, RCSI University of Medicine and Health Sciences, 123, St. Stephen's Green, D02 YN77Dublin 2, Ireland.
  • The Group of Applied Physics, School of Physics, Clinical and Optometric Sciences, Technological University Dublin, D07 ADY7Dublin, Ireland.
  • Molecular Microbiology Division, Faculty of Life Sciences, University of Dundee, Dow St, DundeeDD1 4HN, U.K.

ORCID-Profile: Qingtian Gong, John R F B Connolly, Megan Bergkessel, Marc Devocelle, Clarissa M Czekster

Förderung

  • Royal College of Surgeons in Ireland
  • Tenovus
  • University College Dublin
  • Biotechnology and Biological Sciences Research Council (BBSRC)
  • UK Research and Innovation (UKRI)
  • Science Foundation Ireland

Zitieren

APA

Gong, Q., Synowsky, S., Lynch, A., Connolly, J. R. F. B., Roy, N. S., Shirran, S. L., Bergkessel, M., Devocelle, M., & Czekster, C. M. (2026). Bacterial Aminopeptidase-Activated Peptide Prodrug Enables Species-Selective Targeting of Pseudomonas aeruginosa. ACS Infectious Diseases, 12(9), 3092-3103. https://doi.org/10.1021/acsinfecdis.6c00281

Vancouver

Gong Q, Synowsky S, Lynch A, Connolly JRFB, Roy NS, Shirran SL, et al. Bacterial Aminopeptidase-Activated Peptide Prodrug Enables Species-Selective Targeting of Pseudomonas aeruginosa. ACS Infectious Diseases. 2026;12(9):3092-3103. doi:10.1021/acsinfecdis.6c00281

BibTeX
@article{Gong2026,
  author = {Gong, Qingtian and Synowsky, Silvia and Lynch, Aisling and Connolly, John R F B and Roy, Neeladri Sekhar and Shirran, Sally L and Bergkessel, Megan and Devocelle, Marc and Czekster, Clarissa M},
  title = {Bacterial Aminopeptidase-Activated Peptide Prodrug Enables Species-Selective Targeting of Pseudomonas aeruginosa},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {9},
  pages = {3092--3103},
  doi = {10.1021/acsinfecdis.6c00281}
}
Kostenlos starten →